Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Clinical Diabetes

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1624334

Neurodevelopmental trajectories in well-controlled gestational diabetes mellitus offspring: no differences were found at the 6-and 12-month assessments

Provisionally accepted
Jing  PengJing PengHuazhang  MiaoHuazhang MiaoLi  ZhangLi ZhangJing  JinJing JinLirong  HeLirong HeDongdong  XueDongdong XueYong  GuoYong Guo*Guocheng  LiuGuocheng Liu*
  • Guangdong women and children hospital, Guangzhou, China

The final, formatted version of the article will be published soon.

Objective: To examine the associations between well-controlled gestational diabetes mellitus (GDM) and early neurodevelopmental trajectories in offspring. Methods: This retrospective cohort study included 2810 mother‒infant pairs from Guangdong Women and Children Hospital (2016--2022). GDM was diagnosed via a 75 g oral glucose tolerance test at 24–28 gestational weeks, and women with well-controlled GDM were those who maintained blood glucose levels defined as a third-trimester HbA1c < 6% without requiring medication. Neurodevelopment was assessed via the Children's Neuropsychological and Behavioral Scale-Revision 2016 at 6 and 12 months of age. Results: Among 2810 mother‒infant pairs, 451 (16.05%) were diagnosed with GDM. Compared with non-GDM mothers, mothers with GDM had a greater median age (31.00 vs. 29.00 years; P < 0.001) and prepregnancy BMI (21.26 vs. 20.20 kg/m²; P < 0.001). No significant differences were observed in neonatal sex, birth weight or low birth weight (<2500 g) proportions. Neurodevelopmental assessments at 6 and 12 months revealed no significant differences in gross motor, fine motor, or adaptive behavior; language; or personal‒social scores (all P > 0.05). Adjusted multivariate analyses revealed no associations between GDM and neurodevelopmental delay (≥2 subdomains below the threshold) at 6 months (OR = 0.92, 95% CI: 0.57–1.48; P = 0.739) or 12 months (OR = 0.87, 95% CI: 0.58–1.29; P = 0.479). Conclusions: Well-controlled GDM was not associated with adverse neurodevelopmental outcomes in early infancy, suggesting that optimized perinatal management may mitigate risks.

Keywords: Gestational diabetes mellitus (GDM), development, neurodevelopment, Infant, Blood glucose control

Received: 07 May 2025; Accepted: 26 Aug 2025.

Copyright: © 2025 Peng, Miao, Zhang, Jin, He, Xue, Guo and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Yong Guo, Guangdong women and children hospital, Guangzhou, China
Guocheng Liu, Guangdong women and children hospital, Guangzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.